Evidence map›Paper›PMID 31022220›Full record

ArticlePloS one2019

Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.

Steven G Carmella, Alisa K Heskin, Mei Kuen Tang, Joni Jensen, Xianghua Luo, Chap T Le, Sharon E Murphy, Neal L Benowitz, F Joseph McClernon, Ryan Vandrey and 9 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Association of Urinary Biomarkers of Tobacco Exposure with Lung Cancer Risk in African American and White Cigarette Smokers in the Southern Community Cohort Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Article
  4. Article
  5. Association of Urinary Biomarkers of Smoking-Related Toxicants with Lung Cancer Incidence in Smokers: The Multiethnic Cohort Study.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2023
    Article
  6. Review
  7. Urinary Leukotriene EAmerican journal of respiratory and critical care medicine · 2021
    Observational
  8. Article
  9. Review
  10. Relationships between the Nicotine Metabolite Ratio and a Panel of Exposure and Effect Biomarkers: Findings from Two Studies of U.S. Commercial Cigarette Smokers.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 10 institutions in 1 country.

Steven G CarmellaMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
Alisa K HeskinMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
Mei Kuen TangMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID 0000-0002-4491-8038
Joni JensenMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
Xianghua LuoMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID 0000-0001-7501-6582
Chap T LeMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
Sharon E MurphyMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
Neal L BenowitzDepartment of Medicine, University of California San Francisco, San Francisco, California, United States of America.
F Joseph McClernonDepartment of Psychiatry and Behavioral Sciences, Duke University, Durham, North Carolina, United States of America.
Ryan VandreyDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, Maryland, United States of America.
Sharon S AllenDepartment of Family Medicine and Community Health, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America.
Rachel Denlinger-ApteDepartment of Behavioral and Social Sciences, Brown University, Providence, Rhode Island, United States of America.
Paul M CinciripiniDepartment of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Andrew A StrasserDepartment of Psychiatry, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
Mustafa al'AbsiBehavioral Medicine Laboratories, University of Minnesota Medical School, Duluth, Minnesota, United States of America.
Jason D RobinsonDepartment of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Eric C DonnyDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America.
Dorothy K HatsukamiMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.
Stephen S HechtMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States of America.ORCID 0000-0001-7228-1356
University of Minnesota · USThe University of Texas MD Anderson Cancer Center · USBrown University · USDuke University · USJohns Hopkins University · USUniversity of California, San Francisco · USUniversity of Minnesota, Duluth · USUniversity of Minnesota Medical Center · USUniversity of Pennsylvania · USWake Forest University · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Timothy C. Hallstrom · 1998 to 2026
$100.4M
VERY LOW NICOTINE CIGARETTES IN SMOKERS WITH SCHIZOPHRENIAU54DA031659 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HATSUKAMI, DOROTHY K · 2011 to 2022
$64.7M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR002494 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R, WEISDORF, DANIEL J · 2018 to 2022
$34.9M
Stress, Appetite, and Smoking RelapseR01DA027232 · NIDA · UNIVERSITY OF MINNESOTA · PI AL'ABSI, MUSTAFA, LEE, DUSTIN CLARK · 2010 to 2025
$4.6M
Stress Response and Opioid Dysfunction in Nicotine DependenceR01DA016351 · NIDA · UNIVERSITY OF MINNESOTA DULUTH · PI AL'ABSI, MUSTAFA · 2003 to 2023
$4.5M
NCATS NIH HHS UL1 TR002494NCI NIH HHS P30 CA077598NIDA NIH HHS R01 DA016351NIDA NIH HHS R01 DA027232NIDA NIH HHS U54 DA031659
6 · The paper itself

Abstract

The urinary metabolites (Z)-7-[1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid (8-iso-PGF2α), an F2-isoprostane and biomarker of oxidative damage, and "prostaglandin E2 metabolite" (PGE-M), a biomarker of inflammation, are elevated in cigarette smokers. However, there is little information in the literature on the longitudinal stability of these widely used biomarkers. In a large clinical trial involving 10 institutional sites, smokers were given, free of charge over a period of 20 weeks, Spectrum NRC600/601 research cigarettes containing 15.5 mg nicotine/g tobacco. All participants were instructed to smoke these cigarettes for the duration of the study. At weeks 4, 8, 12, 16, and 20, first morning urine voids were collected and analyzed for 8-iso-PGF2α and PGE-M using validated liquid chromatography-electrospray ionization-tandem mass spectrometry methods. The mean level of 8-iso-PGF2α at Week 4 was 1.34 ± 1.08 (S.D.) pmol/mg creatinine (N = 226) while that of PGE-M was 73.7 ± 113 (S.D.) pmol/mg creatinine (N = 232). The corresponding levels at Week 20 were 1.35 ± 0.93 (S.D.) pmol/mg creatinine (N = 209) for 8-iso-PGF2α and 74.2 ± 142 (S.D.) pmol/mg creatinine (N = 210) for PGE-M. There was variation in these values in the intervening weeks. The intra-class correlation coefficients (ICC) were 0.51 (95% CI, 0.45, 0.57) and 0.36 (0.30, 0.43), for 8-iso-PGF2α and PGE-M, respectively, indicating fair longitudinal stability for 8-iso-PGF2α and poorer longitudinal stability for PGE-M in cigarette smokers. Males had higher ICC values than females for both 8-iso-PGF2α and PGE-M. These results indicate that, in addition to cigarette smoking, endogenous processes of oxidative damage and inflammation influence the levels of these biomarkers over time among current smokers.

Indexed as

Oxidative StressBiomarkersBody Mass IndexCigarette SmokingDinoprostEicosanoidsF2-IsoprostanesFemaleHumansInflammationMaleMetabolomeMiddle Aged8-epi-prostaglandin F2alphaBiomarkersDinoprostEicosanoidsF2-Isoprostanes

Identifiers

PMID31022220
PMCPMC6483352
OpenAlexW2942458113

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.